Bill
Bill > HR7174
US HR7174
US HR7174To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
summary
Introduced
01/31/2024
01/31/2024
In Committee
12/17/2024
12/17/2024
Crossed Over
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
A BILL To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
AI Summary
This bill amends the Social Security Act to equalize the negotiation period for small-molecule and biologic drug candidates under the Drug Price Negotiation Program. Specifically, it increases the negotiation period for small-molecule drugs from 7 years to 11 years, aligning it with the existing 11-year negotiation period for biologic drugs. The amendment takes effect as if it was included in the original enactment of Public Law 117-169.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (18)
Greg Murphy (R)*,
Rick Allen (R),
Dan Crenshaw (R),
John Curtis (R),
Don Davis (D),
Neal Dunn (R),
Josh Gottheimer (D),
Brett Guthrie (R),
John James (R),
Tom Kean (R),
Nicole Malliotakis (R),
Richard McCormick (R),
Carol Miller (R),
Mariannette Miller-Meeks (R),
Claudia Tenney (R),
David Valadao (R),
Brad Wenstrup (R),
Rudy Yakym (R),
Last Action
Referred to the Subcommittee on Health. (on 12/17/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/house-bill/7174/all-info |
| BillText | https://www.congress.gov/118/bills/hr7174/BILLS-118hr7174ih.pdf |
Loading...